Nerve treatment for heart failure with reduced pumping strength
Part of Heart & circulation clinical trials.
This study tests a new procedure that uses heat to target a nerve near the kidneys. The goal is to reduce heart failure symptoms and improve heart function. It is for people with moderate heart failure who are already on standard medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic heart failure, meaning you take a water pill (diuretic) and have symptoms like shortness of breath or fatigue.
- You are at least 40 years old.
- Your heart's pumping ability is between 20% and 40% (this is called ejection fraction).
- You have been on a stable dose of heart failure medications for at least 30 days.
- You have not had a heart attack, heart procedure, or hospitalization for heart failure in the last 30 days (or 3 months for some procedures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to “turn off” the right greater splanchnic nerve to improve symptoms in people with HFpEF (heart failure with preserved pumping function). If successful, it may reduce shortness of breath and fluid congestion in daily life.
This trial tests a procedure called pulmonary artery denervation (using a catheter to treat nerves in the lung's blood vessels) for people with heart failure who still have a preserved ejection fraction (their heart squeezes normally but doesn't fill properly). The procedure aims to reduce pressure in the lungs and improve symptoms like shortness of breath. Participants must be on stable heart failure medications and have elevated BNP levels, among other requirements.
This trial tests a procedure that uses energy to calm overactive nerves in the kidney, which may help improve heart failure symptoms. It is for people with heart failure who are already on the best available medicines but still have symptoms.
This trial tests a nerve block procedure to improve heart function in people with heart failure and reduced pumping ability. It aims to see if blocking certain nerves can help you feel better and be more active.
This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.